Infección por SARS-CoV-2 y enfermedad de Still del adulto: un vínculo emergente

Mar Gómez-Martí; Begoña Miquel-Veyrat; José Chordá-Ribelles

doi:10.32818/reccmi.a10n2a13

Authors

Mar Gómez-Martí Internal Medicine Department, Manises Hospital, Valencia, Spain https://orcid.org/0009-0008-4080-0439
Begoña Miquel-Veyrat Internal Medicine Service, General University Hospital Consortium of Valencia, Valencia, Spain https://orcid.org/0009-0008-7610-6414
José Chordá-Ribelles Internal Medicine Service, General University Hospital Consortium of Valencia, Valencia, Spain

DOI:

https://doi.org/10.32818/reccmi.a10n2a13

Keywords:

adult-onset Still's disease, hyperferritinemic syndrome, SARS-CoV-2

Abstract

Since the onset of the COVID-19 pandemic, there has been an increasing number of diagnoses of immune-mediated diseases in patients following acute SARS-CoV-2 infection. We present the case of a 69-year-old woman with a recent history of mild SARS-CoV-2 infection, who developed persistent fever and a cutaneous rash. After ruling out infectious and neoplastic causes and reviewing the Yamaguchi criteria, she was diagnosed with adult-onset Still's disease. The patient showed favourable clinical response following the initiation of corticosteroid treatment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol. 2019; 45(4): 394-12. doi: https:// doi,org/10.1080/1040841X.2019.1614904 (último acceso ago. 2025). DOI: https://doi.org/10.1080/1040841X.2019.1614904

Winchester N, Calabrese C, Calabrese LH. The intersection of COVID-19 and autoimmunity: what is our current understanding? Pathog Immun. 2021; 6(1): 31-54. doi: https://doi.org/10.20411/pai.v6i1.417 (último acceso ago. 2025). DOI: https://doi.org/10.20411/pai.v6i1.417

Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020; 383(23): 2255- 73. doi: https://doi.org/10.1056/NEJMra2026131 (último acceso ago. 2025). DOI: https://doi.org/10.1056/NEJMra2026131

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021; 93(1): 250-6. doi: https://doi.org/10.1002/jmv.26232 (último acceso ago. 2025). DOI: https://doi.org/10.1002/jmv.26232

Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020; 19(7): 102573. doi: https://doi.org/10.1016/j.autrev.2020.102573 (último acceso ago. 2025). DOI: https://doi.org/10.1016/j.autrev.2020.102573

Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992; 19(3): 424-30. Accesible en: https://pubmed.ncbi.nlm.nih. gov/1578458/ (último acceso ago. 2025).

Alshablan A, Jabbad R, Tayeb S, Albeshri T, Yelamanchili SR, Rabie N, et al. Clinical Medicine Insights: Case Reports. 2021; 14: 1-3. Doi: https://doi. org/10.1177/1179547621996306 (último acceso ago. 2025). DOI: https://doi.org/10.1177/1179547621996306

Bamidis AD, Koehler P, Di Cristanziano V, Rasche K, Demirel B, Bacher P, et al. First manifestation of adult-onset Still’s disease after COVID-19. Lancet Rheumatol. 2021; 3(5): e295-e297. doi: https://doi.org/10.1016/S2665- 9913(21)00061-9 (último acceso ago. 2025). DOI: https://doi.org/10.1016/S2665-9913(21)00072-2

Matsuda M, Funakubo Asanuma Y, Yokota K, Sakai S, Yazawa H, Maruyama T, et al. New-onset adult-onset Still's disease following COVID-19 vaccination: three case reports and a literature review. Intern Med. 2023; 62(2): 299-305. doi: https://doi.org/10.2169/internalmedicine.0590-22 (último acceso ago. 2025). DOI: https://doi.org/10.2169/internalmedicine.0590-22